The Seattle Times. Winner of Eight Pulitzer Prizes.


Tue, Sep 2, 2014

WEATHER | TRAFFIC

VIEW SECTIONS

Home


Updated Saturday, February 2, 2013 at 12:46 PM

A rare, legitimate Madoff investment goes public

The Associated Press

Jailed Wall Street fraudster Bernie Madoff may have finally picked a legitimate winner.

A biopharmaceutical company partly owned by the Madoff family had an initial public offering Tuesday that sold $33 million worth of stock.

The New York Post reports (http://bit.ly/WJWUPi) that Madoff's initial $2.2 million investment in the company, Stemline Therapeutics, is now worth $5.5 million on paper.

But the scammer might not be able to keep the money.

The trustee overseeing efforts to untangle Madoff's Ponzi scheme says the family's shares rightfully belong to his defrauded clients.

He has filed a lawsuit seeking to seize those shares on behalf of fraud victims.

Madoff is expected to spend the rest of his life in prison.

---

Information from: New York Post, http://www.nypost.com


SECTIONS

Top News arrow

Latest News arrow

Local arrow

Nation & World arrow

Business & Technology arrow

Editorial & Opinion arrow

Sports arrow

Entertainment arrow

Living arrow

Travel & Outdoors arrow

Obituaries arrow


CLASSIFIEDS

Jobs arrow

Autos arrow

Homes & Rentals arrow

More Classifieds arrow